The mass production of pharmaceuticals has significantly evolved since the industrial fabrication of synthetic drugs towards the end of the 19 th century 1 with efficient developments in process ...
A Contamination Control Strategy (CCS) identifies and evaluates contamination risks, explores mitigation options, and sets out plans for corrective and preventive actions. Its implementation addresses ...
As EV battery manufacturing technologies evolve, from coated film to solid-state cells, the industry is facing new contamination challenges that existing processes aren’t equipped to handle. According ...
In this free webinar, see how environmental monitoring in pharma supports contamination control, inspection readiness and a demonstrable state of control. Attendees will learn how to design a ...
Ryan Murray, ValSource, breaks down far UVC technology, holistic contamination control strategies, and environmental monitoring in pharma manufacturing. Ryan Murray, senior consultant, ValSource, ...
In this Pharma Matters Q&A, Amina Rahmoune of Nelson Labs evaluates and compares sterility testing in cleanrooms and isolators.
Contract development and manufacturing organizations can assist sponsor company is ensuring sterility assurance in alignment with the EU’s Annex 1 guidelines. The 2023 revision of Annex 1 of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results